Reply - 14/01/12
Doi : 10.1016/j.jaad.2011.08.029
Lena Ly, MBBS, BMedSc, DipSurgAnat a, b, c, ⁎ 
, Ingrid Winship, MBChB, MD, FRACP, FACD c, d, John William Kelly, MBBS, PhD, FACD b, e
, Ingrid Winship, MBChB, MD, FRACP, FACD c, d, John William Kelly, MBBS, PhD, FACD b, e a Department of Dermatology, Royal Children’s Hospital, Parkville, Melbourne, Victoria, Australia
b Victorian Melanoma Service, Alfred Health, Prahran, Melbourne, Victoria, Australia
c Department of Medicine, University of Melbourne, Parkville, Melbourne, Victoria, Australia
d Adult Clinical Genetics, Royal Melbourne Hospital, Parkville, Melbourne, Victoria, Australia
e Department of Medicine, Monash University, Clayton, Melbourne, Victoria, Australia
Correspondence to: Lena Ly, MBBS, BMedSc, DipSurgAnat, Department of Dermatology, Royal Children’s Hospital, 50 Flemington Rd, Parkville, Melbourne, Victoria 3050, Australia
Il testo completo di questo articolo è disponibile in PDF.
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2011
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 66 - N° 2
P. 325-326 - febbraio 2012 Ritorno al numero
Articolo precedente
- Segmentally grouped melanocytic nevi and melanoma risk
- Daniele Torchia
- Long-term prognosis of vitiligo patients on narrowband UVB phototherapy
- Kelly K. Park, Jenny E. Murase, John Koo
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?